Professor Peter Clayton

Peter Clayton is Emeritus Professor of Child Health and Paediatric Endocrinology at the University of Manchester. For 30 years he has been a clinical consultant at the Royal Manchester Children’s Hospital and at the Christie (Cancer) Hospital. His primary research interest is centred on understanding mechanisms leading to disordered growth, using clinical, genomic, in-vitro and in-vivo approaches. He has led a research team of clinicians and scientists, whose work has spanned basic science through to clinical trials, with a focus on translation to patient care. His clinical interests include late endocrine effects of childhood cancer treatment and the transition of young people with chronic endocrine conditions through to adult care. He now advises on clinical trials for an oral growth hormone secretagogue in growth disorders